Molecular and fate maps of prostatic stroma
前列腺基质的分子和命运图谱
基本信息
- 批准号:9492866
- 负责人:
- 金额:$ 6.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-15 至 2021-05-31
- 项目状态:已结题
- 来源:
- 关键词:Alpha CellAndrogen ReceptorAntibodiesAntineoplastic AgentsAtlasesBehaviorBenignBenign Prostatic HypertrophyBiologyCell LineageCellsChadClinicalCommunitiesComplementComplexDataData SetDatabasesDaughterDevelopmentDimensionsDiseaseDrug TargetingDuct (organ) structureDuctalEpithelialEpithelial CellsEpitheliumExtracellular MatrixFibroblastsFoundationsFunctional disorderGene ExpressionGenerationsGeneticGenetic TranscriptionGoalsGrowthGrowth FactorGrowth Factor ReceptorsHomeostasisHormonesHumanHyperplasiaImageInflammationInflammatory ResponseKnowledgeLabelLinkMalignant NeoplasmsMapsMediatingMessenger RNAMolecularMusMuscleMuscle CellsOrganPainParacrine CommunicationPathogenesisPathogenicityPathway interactionsPatternPericytesPharmacologyPopulationPositioning AttributePrincipal InvestigatorProcessProliferatingProstateProstaticProstatic DiseasesProstatic StromaProteinsPublicationsRNAResearchResearch PersonnelResolutionResourcesRodentRoleSignal PathwaySignal TransductionSmooth MuscleSmooth Muscle MyocytesSpecimenSphincterStriated MusclesStromal CellsTechnologyTestingTissuesUrethraUrologyWorkarmbasecell behaviorcell typedaughter celldesignexperiencefetalgenetic approachgenetic manipulationhuman datainnovationinterestmaleonline tutorialprogenitorprogramsprotein expressionregenerativerepairedresistance factorsspectrographstromal progenitortime usetooltranscription factorurinary
项目摘要
PROJECT SUMMARY
An impressive suite of tools is available for studying prostatic epithelial cells; surprisingly few exist for
prostatic stroma, even though it drives most of the prostate's significant biologic behaviors. Prostatic stroma
initiates glandular development and releases paracrine signals that stimulate epithelial growth during benign
hyperplasia and cancer. It also synthesizes extracellular matrix molecules that mediate regenerative repair and
increase organ stiffness, factors recently associated with urinary dysfunction. Pinpointing prostatic stromal
progenitors and factors involved in their proliferation and differentiation are the first steps in identifying cellular
mechanisms responsible for stroma-based disease processes. Our first aim uses a mouse genetic approach to
identify progenitors giving rise to prostatic fibroblasts, smooth muscle cells, perivascular cells and urinary striated
muscle sphincter myocytes. We will use immunostaining and multispectral imaging to assign lineage labeled
cells to two- and three—dimensional maps of prostatic stromal sub-compartments. These data will be presented
using an innovative online tool that connects researchers with validated cre-expressing mouse lines and stromal-
cell selective antibodies. Our second aim is to create a developing human prostatic stroma RNA and protein
expression atlas to stimulate hypotheses that are relevant to prostatic disease causing behaviors of stromal
progenitors identified in Aim 1. We will map expression patterns for key growth factors, receptors, and
transcription factors that potentially mediate prostatic stromal and epithelial differentiation. This work
complements the high-resolution developing mouse prostatic atlas we made previously for GUDMAP. Our results
will be used to generate online tutorials of prostate development and we will identify homologous compartments
between mouse and human. We will annotate human data when possible with the same terms used previously
to annotate mouse data, providing a searchable online dataset which enables investigators to compare
RNA/protein expression between mouse and human and identify conserved pathways across species. Our data
will equip the prostate research community with the necessary tools to design and test new hypotheses about
the pathogenic role of prostatic stroma in benign hyperplasia, inflammation, pain, and cancer.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHAD M. VEZINA其他文献
CHAD M. VEZINA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHAD M. VEZINA', 18)}}的其他基金
Role of DNA methylation in prostate glandular development and urinary function
DNA甲基化在前列腺发育和泌尿功能中的作用
- 批准号:
8761606 - 财政年份:2014
- 资助金额:
$ 6.57万 - 项目类别:
Role of DNA methylation in prostate glandular development and urinary function
DNA甲基化在前列腺发育和泌尿功能中的作用
- 批准号:
8891417 - 财政年份:2014
- 资助金额:
$ 6.57万 - 项目类别:
Role of DNA methylation in prostate glandular development and urinary function
DNA甲基化在前列腺发育和泌尿功能中的作用
- 批准号:
9315002 - 财政年份:2014
- 资助金额:
$ 6.57万 - 项目类别:
Wisconsin Multidisciplinary K12 Urologic Research Career Development Program
威斯康星州多学科 K12 泌尿学研究职业发展计划
- 批准号:
10731262 - 财政年份:2013
- 资助金额:
$ 6.57万 - 项目类别:
The Epigenome: A New Target for Androgen Receptor in Developing Prostate
表观基因组:雄激素受体在前列腺发育中的新靶点
- 批准号:
8514595 - 财政年份:2012
- 资助金额:
$ 6.57万 - 项目类别:
The Epigenome: A New Target for Androgen Receptor in Developing Prostate
表观基因组:雄激素受体在前列腺发育中的新靶点
- 批准号:
8358446 - 财政年份:2012
- 资助金额:
$ 6.57万 - 项目类别:
相似海外基金
Androgen receptor: A master regulator of lipid metabolism
雄激素受体:脂质代谢的主要调节因子
- 批准号:
DP230103210 - 财政年份:2023
- 资助金额:
$ 6.57万 - 项目类别:
Discovery Projects
Regulation of androgen receptor signaling in prostate cancer by protein arginine methylation
通过蛋白质精氨酸甲基化调节前列腺癌中的雄激素受体信号传导
- 批准号:
10584689 - 财政年份:2023
- 资助金额:
$ 6.57万 - 项目类别:
Structural and functional analysis of a novel class of androgen receptor antagonists
一类新型雄激素受体拮抗剂的结构和功能分析
- 批准号:
10650956 - 财政年份:2023
- 资助金额:
$ 6.57万 - 项目类别:
Role of the Androgen Receptor in Insulin Secretion in the Male
雄激素受体在男性胰岛素分泌中的作用
- 批准号:
10488954 - 财政年份:2023
- 资助金额:
$ 6.57万 - 项目类别:
Targeting tumor cell macrophage lipid interactions to overcome resistance to androgen receptor targeted therapy
靶向肿瘤细胞巨噬细胞脂质相互作用以克服对雄激素受体靶向治疗的耐药性
- 批准号:
10651105 - 财政年份:2023
- 资助金额:
$ 6.57万 - 项目类别:
Preclinical development of ONCT-505, an Androgen Receptor Antagonist and Degrader, as new potential therapeutic for Kennedy's Disease
ONCT-505(一种雄激素受体拮抗剂和降解剂)的临床前开发,作为肯尼迪病的新潜在治疗方法
- 批准号:
10603636 - 财政年份:2023
- 资助金额:
$ 6.57万 - 项目类别:
Proliferating cell nuclear antigen in regulation of androgen receptor signalings in castration-resistant prostate cancer cells
增殖细胞核抗原对去势抵抗性前列腺癌细胞雄激素受体信号传导的调节
- 批准号:
10544062 - 财政年份:2022
- 资助金额:
$ 6.57万 - 项目类别:
Effects of androgen receptor (AR) signaling on CD4+ T cell metabolism during airway inflammation
气道炎症期间雄激素受体 (AR) 信号对 CD4 T 细胞代谢的影响
- 批准号:
10534943 - 财政年份:2022
- 资助金额:
$ 6.57万 - 项目类别:
TITLE: BLADDER CANCER CHEMOPREVENTION USING THE ANDROGEN RECEPTOR INHIBITOR APALUTAMIDE
标题:使用雄激素受体抑制剂阿帕鲁胺进行膀胱癌化学预防
- 批准号:
10677989 - 财政年份:2022
- 资助金额:
$ 6.57万 - 项目类别:














{{item.name}}会员




